Results 41 to 50 of about 14,897 (305)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome [PDF]

open access: yes, 2019
When hypertension, a pathology that is frequently found in the general population, presents in a young patient, secondary causes such as Cushing's syndrome (CS), a rare disease characterized by long-term elevated cortisol levels, should be considered ...
Barbot, Mattia   +2 more
core   +1 more source

Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment

open access: yesJFMS open reports, 2021
Case summary Three diabetic cats presented with polyuria, polydipsia, polyphagia and poor glycemic control. Cat 1 displayed prognathia inferior and had a body condition score (BCS) of 4/5; cat 2 had a BCS of 5/5; and cat 3 had broad facial features ...
D. Miceli   +5 more
semanticscholar   +1 more source

Cabergoline vs intravenous albumin or combination of both for prevention of the early onset ovarian hyperstimulation syndrome

open access: yesMiddle East Fertility Society Journal, 2011
Background: Prophylactic use of dopamine agonist has been associated with a decrease in the severity of ovarian hyperstimulation syndrome (OHSS). Objective: To compare cabergoline with cabergoline plus I.V albumin or I.V albumin alone in prevention of ...
Badeea S. Soliman
doaj   +1 more source

Uso de lanreotida en combinación con cabergolina o pegvisomant en la práctica clínica en pacientes con acromegalia: el estudio ACROCOMB [PDF]

open access: yes, 2016
[Abstract] PURPOSE: To describe real-world use of lanreotide combination therapy for acromegaly. PATIENTS AND METHODS: ACROCOMB is a retrospective observational Spanish study of patients with active acromegaly treated with lanreotide combination therapy
Bernabéu, Ignacio   +18 more
core   +2 more sources

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma

open access: yesEndocrine Oncology, 2023
Cabergoline-associated valvulopathy (CAV) is defined by the echocardiographic triad of moderate or severe regurgitation, valvular thickening and restricted valvular motion.
Annabelle G Hayes   +4 more
doaj   +1 more source

Advances in the treatment of prolactinomas [PDF]

open access: yes, 2006
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of ...
1997 Data on file   +627 more
core   +1 more source

Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection [PDF]

open access: yesInternational Journal of Fertility and Sterility, 2018
Background The aim of the current study is to compare quinagolide with cabergoline in prevention of ovarian hyperstimulation syndrome (OHSS) among high risk women undergoing intracytoplasmic sperm injection (ICSI).
Robabeh Taheripanah   +3 more
doaj   +1 more source

Análise de custo-efetividade de análogos da somatostatina no tratamento de acromegalia no Brasil [PDF]

open access: yes, 2008
This study aims to compare economic and patient impacts of the treatment of acromegaly with two different somatostatin analogues (octreotide LAR and lanreotide SR) in Brazil. A cost-effectiveness analysis was carried out under the Brazilian Public Health
CALABRÓ, Alessandra   +3 more
core   +3 more sources

Medical treatment of Cushing's syndrome: Adrenal-blocking drugs and ketaconazole [PDF]

open access: yes, 2010
Cushing's syndrome is associated with serious morbidity and increased mortality. Irrespective of its cause, i.e. a pituitary adenoma, ectopic ACTH production or an adrenal neoplasia, Cushing's syndrome is primarily treated surgically.
Feelders, R.A. (Richard)   +2 more
core   +7 more sources

Comparative efficacy and safety of generic (Bergolak) vs. brand cabergoline in the treatment of patients with prolactin-secreting tumors

open access: yesОжирение и метаболизм, 2015
Objective: To evaluate the effectiveness and safety of cabergoline drug Bergolak («Veropharm», Russia) in the treatment of patients with prolactin-secreting tumors.Materials and methods: The study included 14 patients (14 women, mean age 46±12) diagnosed
Galina Afanas'evna Melnichenko   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy